Arising Merck Product IP

Arising Merck Product IP. Such Arising Intellectual Property that (a) is conceived and/or reduced to practice in the course of, or as a result of, performance of the Research and CMC Plan and associated Work Orders; and (b) relates specifically to any of the following: (i) a Collaboration Candidate, CAR-NK Cell expressing a CAR containing an Antibody Binder directed to a Collaboration Target, or a CAR structure containing an Antibody Binder directed to a Collaboration Target, including compositions, methods of use or... processes of manufacture that are specific to the manufacture or use of any such Collaboration Candidate, CAR-NK Cell, or CAR structure, as applicable; (ii) Antibody Binders (including compositions, methods of use, or processes of manufacture of an Antibody Binder); or (iii) any other Arising Intellectual Property that is not Arising GCLC Core IP View More